Recently a novel subgroup of bronchiolitis obliterans syndrome (BOS) has been described in patients after lung transplantation with high neutrophil counts in broncho-alveolar lavage and recovery of lung functional decline with azithromycin treatment. We aimed to describe the thin-section computed tomography (CT) findings of these neutrophilic reversible allograft dysfunction (NRAD) patients before and after azithromycin.status: publishe
Chronic lung allograft dysfunction (CLAD) remains a major hurdle limiting long-term survival post lu...
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, cau...
Bronchiolitis obliterans syndrome (BOS) is a progressive, insidious, and often fatal lung alloreacti...
Lung transplantation is currently considered as an ultimate live-saving treatment for selected patie...
WINNING ABSTRACT: BOS is the most important cause of late mortality after LTx. Until 5 years ago, th...
Bronchiolitis obliterans syndrome (BOS) is the leading cause of death in lung transplant recipients ...
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is the leading cause of morbidity/mortality in l...
Azithromycin decreases airway neutrophilia and can prevent chronic lung allograft dysfunction (CLAD)...
In the present case report we have described a 46-year-old female patient who underwent a liver tran...
A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) pos...
BACKGROUND: Azithromycin may reverse or halt the decline of pulmonary function (FEV(1)) in bronchiol...
Long-term survival after LTx is limited, mainly attributed to the development of chronic lung allogr...
To describe the CT changes in patients with restrictive allograft syndrome (RAS) after lung transpla...
High-resolution computed tomography (HRCT) has been described to be useful in assessing bronchioliti...
Chronic lung allograft dysfunction (CLAD) remains the major barrier to long-term success after lung ...
Chronic lung allograft dysfunction (CLAD) remains a major hurdle limiting long-term survival post lu...
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, cau...
Bronchiolitis obliterans syndrome (BOS) is a progressive, insidious, and often fatal lung alloreacti...
Lung transplantation is currently considered as an ultimate live-saving treatment for selected patie...
WINNING ABSTRACT: BOS is the most important cause of late mortality after LTx. Until 5 years ago, th...
Bronchiolitis obliterans syndrome (BOS) is the leading cause of death in lung transplant recipients ...
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is the leading cause of morbidity/mortality in l...
Azithromycin decreases airway neutrophilia and can prevent chronic lung allograft dysfunction (CLAD)...
In the present case report we have described a 46-year-old female patient who underwent a liver tran...
A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) pos...
BACKGROUND: Azithromycin may reverse or halt the decline of pulmonary function (FEV(1)) in bronchiol...
Long-term survival after LTx is limited, mainly attributed to the development of chronic lung allogr...
To describe the CT changes in patients with restrictive allograft syndrome (RAS) after lung transpla...
High-resolution computed tomography (HRCT) has been described to be useful in assessing bronchioliti...
Chronic lung allograft dysfunction (CLAD) remains the major barrier to long-term success after lung ...
Chronic lung allograft dysfunction (CLAD) remains a major hurdle limiting long-term survival post lu...
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, cau...
Bronchiolitis obliterans syndrome (BOS) is a progressive, insidious, and often fatal lung alloreacti...